 | • レポートコード：QYR9ST03851 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、慢性骨髄性白血病治療の世界市場について調査・分析し、慢性骨髄性白血病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（疾患特異的治療、対症療法）、用途別（病院薬局、専門薬局、小売薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の慢性骨髄性白血病治療市場動向 ・主要企業別マーケットシェア ・慢性骨髄性白血病治療の種類別市場規模2014-2019 （疾患特異的治療、対症療法） ・慢性骨髄性白血病治療の用途別市場規模2014-2019 （病院薬局、専門薬局、小売薬局） ・慢性骨髄性白血病治療の北米市場：主要企業・種類別/用途別市場規模 ・慢性骨髄性白血病治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・慢性骨髄性白血病治療の中国市場：主要企業・種類別/用途別市場規模 ・慢性骨髄性白血病治療の日本国内市場：主要企業・種類別/用途別市場規模 ・慢性骨髄性白血病治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・慢性骨髄性白血病治療のインド市場：主要企業・種類別/用途別市場規模 ・慢性骨髄性白血病治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol-Myers Squibb、Novartis、Pfizer、Teva Pharmaceuticals、Roche、Incyte、Bio-Path Holdings） ・慢性骨髄性白血病治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It’s a type of cancer that starts in certain blood-forming cells of the bone marrow.In 2018, the global Chronic Myelogenous Leukemia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Chronic Myelogenous Leukemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Myelogenous Leukemia Treatment development in United States, Europe and China.
The key players covered in this study
Bristol-Myers Squibb
Novartis
Pfizer
Teva Pharmaceuticals
Roche
Incyte
Bio-Path Holdings
…
Market segment by Type, the product can be split into
Disease Specific Treatment
Symptomatic Treatment
Market segment by Application, split into
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Chronic Myelogenous Leukemia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Chronic Myelogenous Leukemia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Chronic Myelogenous Leukemia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chronic Myelogenous Leukemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Disease Specific Treatment
1.4.3 Symptomatic Treatment
1.5 Market by Application
1.5.1 Global Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Specialty Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Chronic Myelogenous Leukemia Treatment Market Size
2.2 Chronic Myelogenous Leukemia Treatment Growth Trends by Regions
2.2.1 Chronic Myelogenous Leukemia Treatment Market Size by Regions (2014-2025)
2.2.2 Chronic Myelogenous Leukemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Chronic Myelogenous Leukemia Treatment Market Size by Manufacturers
3.1.1 Global Chronic Myelogenous Leukemia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Chronic Myelogenous Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Myelogenous Leukemia Treatment Key Players Head office and Area Served
3.3 Key Players Chronic Myelogenous Leukemia Treatment Product/Solution/Service
3.4 Date of Enter into Chronic Myelogenous Leukemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Chronic Myelogenous Leukemia Treatment Market Size by Type (2014-2019)
4.2 Global Chronic Myelogenous Leukemia Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Chronic Myelogenous Leukemia Treatment Market Size (2014-2019)
5.2 Chronic Myelogenous Leukemia Treatment Key Players in United States
5.3 United States Chronic Myelogenous Leukemia Treatment Market Size by Type
5.4 United States Chronic Myelogenous Leukemia Treatment Market Size by Application
6 Europe
6.1 Europe Chronic Myelogenous Leukemia Treatment Market Size (2014-2019)
6.2 Chronic Myelogenous Leukemia Treatment Key Players in Europe
6.3 Europe Chronic Myelogenous Leukemia Treatment Market Size by Type
6.4 Europe Chronic Myelogenous Leukemia Treatment Market Size by Application
7 China
7.1 China Chronic Myelogenous Leukemia Treatment Market Size (2014-2019)
7.2 Chronic Myelogenous Leukemia Treatment Key Players in China
7.3 China Chronic Myelogenous Leukemia Treatment Market Size by Type
7.4 China Chronic Myelogenous Leukemia Treatment Market Size by Application
8 Japan
8.1 Japan Chronic Myelogenous Leukemia Treatment Market Size (2014-2019)
8.2 Chronic Myelogenous Leukemia Treatment Key Players in Japan
8.3 Japan Chronic Myelogenous Leukemia Treatment Market Size by Type
8.4 Japan Chronic Myelogenous Leukemia Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size (2014-2019)
9.2 Chronic Myelogenous Leukemia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size by Type
9.4 Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size by Application
10 India
10.1 India Chronic Myelogenous Leukemia Treatment Market Size (2014-2019)
10.2 Chronic Myelogenous Leukemia Treatment Key Players in India
10.3 India Chronic Myelogenous Leukemia Treatment Market Size by Type
10.4 India Chronic Myelogenous Leukemia Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Chronic Myelogenous Leukemia Treatment Market Size (2014-2019)
11.2 Chronic Myelogenous Leukemia Treatment Key Players in Central & South America
11.3 Central & South America Chronic Myelogenous Leukemia Treatment Market Size by Type
11.4 Central & South America Chronic Myelogenous Leukemia Treatment Market Size by Application
12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chronic Myelogenous Leukemia Treatment Introduction
12.1.4 Bristol-Myers Squibb Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chronic Myelogenous Leukemia Treatment Introduction
12.2.4 Novartis Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chronic Myelogenous Leukemia Treatment Introduction
12.3.4 Pfizer Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Teva Pharmaceuticals
12.4.1 Teva Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chronic Myelogenous Leukemia Treatment Introduction
12.4.4 Teva Pharmaceuticals Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
12.4.5 Teva Pharmaceuticals Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Chronic Myelogenous Leukemia Treatment Introduction
12.5.4 Roche Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Incyte
12.6.1 Incyte Company Details
12.6.2 Company Description and Business Overview
12.6.3 Chronic Myelogenous Leukemia Treatment Introduction
12.6.4 Incyte Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
12.6.5 Incyte Recent Development
12.7 Bio-Path Holdings
12.7.1 Bio-Path Holdings Company Details
12.7.2 Company Description and Business Overview
12.7.3 Chronic Myelogenous Leukemia Treatment Introduction
12.7.4 Bio-Path Holdings Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
12.7.5 Bio-Path Holdings Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Chronic Myelogenous Leukemia Treatment Key Market Segments
Table Key Players Chronic Myelogenous Leukemia Treatment Covered
Table Global Chronic Myelogenous Leukemia Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Chronic Myelogenous Leukemia Treatment Market Size Market Share by Type 2014-2025
Figure Disease Specific Treatment Figures
Table Key Players of Disease Specific Treatment
Figure Symptomatic Treatment Figures
Table Key Players of Symptomatic Treatment
Table Global Chronic Myelogenous Leukemia Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Specialty Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Chronic Myelogenous Leukemia Treatment Report Years Considered
Table Global Chronic Myelogenous Leukemia Treatment Market Size 2014-2025 (Million US$)
Figure Global Chronic Myelogenous Leukemia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Chronic Myelogenous Leukemia Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Chronic Myelogenous Leukemia Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Chronic Myelogenous Leukemia Treatment Market Share by Regions 2014-2019
Figure Global Chronic Myelogenous Leukemia Treatment Market Share by Regions 2014-2019
Figure Global Chronic Myelogenous Leukemia Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Chronic Myelogenous Leukemia Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Chronic Myelogenous Leukemia Treatment Market Share by Manufacturers (2014-2019)
Figure Global Chronic Myelogenous Leukemia Treatment Market Share by Manufacturers in 2018
Table Global Chronic Myelogenous Leukemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Chronic Myelogenous Leukemia Treatment Product/Solution/Service
Table Date of Enter into Chronic Myelogenous Leukemia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Chronic Myelogenous Leukemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Chronic Myelogenous Leukemia Treatment Market Size Share by Type (2014-2019)
Figure Global Chronic Myelogenous Leukemia Treatment Market Size Market Share by Type (2014-2019)
Table Global Chronic Myelogenous Leukemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Chronic Myelogenous Leukemia Treatment Market Size Share by Application (2014-2019)
Figure Global Chronic Myelogenous Leukemia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Application in 2018
Figure United States Chronic Myelogenous Leukemia Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Chronic Myelogenous Leukemia Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Chronic Myelogenous Leukemia Treatment Market Share (2018-2019)
Table United States Chronic Myelogenous Leukemia Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Chronic Myelogenous Leukemia Treatment Market Share by Type (2014-2019)
Table United States Chronic Myelogenous Leukemia Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2019)
Figure Europe Chronic Myelogenous Leukemia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Chronic Myelogenous Leukemia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Chronic Myelogenous Leukemia Treatment Market Share (2018-2019)
Table Europe Chronic Myelogenous Leukemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Chronic Myelogenous Leukemia Treatment Market Share by Type (2014-2019)
Table Europe Chronic Myelogenous Leukemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2019)
Figure China Chronic Myelogenous Leukemia Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Chronic Myelogenous Leukemia Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Chronic Myelogenous Leukemia Treatment Market Share (2018-2019)
Table China Chronic Myelogenous Leukemia Treatment Market Size by Type (2014-20189) (Million US$)
Table China Chronic Myelogenous Leukemia Treatment Market Share by Type (2014-2019)
Table China Chronic Myelogenous Leukemia Treatment Market Size by Application (2014-2019) (Million US$)
Table China Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2019)
Figure Japan Chronic Myelogenous Leukemia Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Chronic Myelogenous Leukemia Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Chronic Myelogenous Leukemia Treatment Market Share (2018-2019)
Table Japan Chronic Myelogenous Leukemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Chronic Myelogenous Leukemia Treatment Market Share by Type (2014-2019)
Table Japan Chronic Myelogenous Leukemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Chronic Myelogenous Leukemia Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Chronic Myelogenous Leukemia Treatment Market Share (2018-2019)
Table Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Chronic Myelogenous Leukemia Treatment Market Share by Type (2014-2019)
Table Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2019)
Figure India Chronic Myelogenous Leukemia Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Chronic Myelogenous Leukemia Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Chronic Myelogenous Leukemia Treatment Market Share (2018-2019)
Table India Chronic Myelogenous Leukemia Treatment Market Size by Type (2014-2019) (Million US$)
Table India Chronic Myelogenous Leukemia Treatment Market Share by Type (2014-2019)
Table India Chronic Myelogenous Leukemia Treatment Market Size by Application (2014-2019) (Million US$)
Table India Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2019)
Figure Central & South America Chronic Myelogenous Leukemia Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Chronic Myelogenous Leukemia Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Chronic Myelogenous Leukemia Treatment Market Share (2018-2019)
Table Central & South America Chronic Myelogenous Leukemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Chronic Myelogenous Leukemia Treatment Market Share by Type (2014-2019)
Table Central & South America Chronic Myelogenous Leukemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Novartis Company Details
Table Novartis Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Teva Pharmaceuticals Company Details
Table Teva Pharmaceuticals Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceuticals Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
Table Teva Pharmaceuticals Recent Development
Table Roche Company Details
Table Roche Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
Table Roche Recent Development
Table Incyte Company Details
Table Incyte Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)(Million US$)
Figure Incyte Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
Table Incyte Recent Development
Table Bio-Path Holdings Company Details
Table Bio-Path Holdings Revenue in Chronic Myelogenous Leukemia Treatment Business (2014-2019)(Million US$)
Figure Bio-Path Holdings Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2014-2019)
Table Bio-Path Holdings Recent Development
Table Global Chronic Myelogenous Leukemia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Chronic Myelogenous Leukemia Treatment Market Size Share by Regions (2019-2025)
Figure Global Chronic Myelogenous Leukemia Treatment Market Size Share by Regions in 2025
Figure United States Chronic Myelogenous Leukemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Chronic Myelogenous Leukemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Chronic Myelogenous Leukemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Chronic Myelogenous Leukemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Chronic Myelogenous Leukemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Chronic Myelogenous Leukemia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Chronic Myelogenous Leukemia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Chronic Myelogenous Leukemia Treatment Market Size by Product (2019-2025)
Figure Global Chronic Myelogenous Leukemia Treatment Market Size by Product in 2025
Table Global Chronic Myelogenous Leukemia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Chronic Myelogenous Leukemia Treatment Market Size by Application (2019-2025)
Figure Global Chronic Myelogenous Leukemia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の慢性気管支炎治療市場：専門的調査 Bronchitis is a respiratory disease that causes inflammation in the airways, also known as bronchi, of the lungs. It leads to irritation and inflammation of the lining of bronchial tubes, which are responsible for carrying air to and from the lungs. The global Chronic Bronchitis Treatment market was…- 世界の慢性気管支炎治療市場：専門的調査 Bronchitis is a respiratory disease that causes inflammation in the airways, also known as bronchi, of the lungs. It leads to irritation and inflammation of the lining of bronchial tubes, which are responsible for carrying air to and from the lungs. The global Chronic Bronchitis Treatment market was…
- 有毛細胞白血病治療の世界市場：市場規模・現状・予測 Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells.It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can …
- 白血病治療薬の世界市場：市場規模・現状・予測 Leukemia Treatment Drugs is used to cure Leukemia.Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. In 2018, the global Leukemia Treatment Drugs market size was xx million US$ an…
- 慢性肺疾患治療の世界市場：市場規模・現状・予測 Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in r…